Patent · US Expired

Progesterone tablet and its manufacturing process

US6086916A · kind A · utility

72Cited by

4References

11Claims

0Family size

Assignee

Laboratoires Besins Iscovesco · FR

Inventors

Benoit Agnus · Bry-sur-Marne, FR
Antoine Besins · Paris, FR

Key dates

Filing date	Mar 16, 1999
Grant date	Jul 11, 2000
Priority date	—
Expiry date	Mar 16, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/57
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns a progesterone tablet characterised by the fact that its excipient content is at most 45%, preferably at most 40%, and yet more preferably at most 38%, the percentages being expressed in weight relative to the total dry matter of the tablet.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.